Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. The company offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. It also provides HPV and cervical cancer testing services, respiratory infection detection solution, solutions for infectious diarrhea, and STI detection solution for reproductive tract infections. In addition, the company offers biological technology platforms, including nucleic acid detection platforms, NGS technology platforms, POCT technology platforms, mass spectrometry technology platforms, and automated control and detection platforms. Jiangsu Bioperfectus Technologies Co., Ltd. was founded in 2010 and is headquartered in Taizhou, China.
Frequently asked questions
What sector does Jiangsu Bioperfectus Technologies Co Ltd (688399) operate in?
Jiangsu Bioperfectus Technologies Co Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Jiangsu Bioperfectus Technologies Co Ltd (688399) current stock price?
As of the latest data, Jiangsu Bioperfectus Technologies Co Ltd stock price is CN¥24.57, with a previous close of CN¥24.14. Jiangsu Bioperfectus Technologies Co Ltd gained CN¥0.43 in the last trading session, representing a 1.78% increase.
What is Jiangsu Bioperfectus Technologies Co Ltd (688399) current market capitalization?
Jiangsu Bioperfectus Technologies Co Ltd market cap is approximately 3.05 billion.
What is Jiangsu Bioperfectus Technologies Co Ltd (688399) Earnings Per Share (EPS)?
The trailing EPS is -CN¥0.20.
Does Jiangsu Bioperfectus Technologies Co Ltd (688399) pay dividends?
No. Jiangsu Bioperfectus Technologies Co Ltd does not pay a dividend.
What is Jiangsu Bioperfectus Technologies Co Ltd (688399) beta (volatility) score?
Jiangsu Bioperfectus Technologies Co Ltd has a beta of 0.750, indicating lower volatility than the overall market.
